Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-02-23 Purchase |
2022-02-24 7:15 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
17,500 | $3.6543 | $63,950 | 5,225,786 (Direct) |
View |
2022-02-23 Purchase |
2022-02-24 7:12 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
17,500 | $3.6543 | $63,950 | 5,225,786 (Indirect) |
View |
2022-02-17 Purchase |
2022-02-22 11:36 am |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
19,949 | $4.0196 | $80,187 | 5,208,286 (Indirect) |
View |
2022-02-17 Purchase |
2022-02-22 11:35 am |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
19,949 | $4.0196 | $80,187 | 5,208,286 (Direct) |
View |
2022-02-14 Purchase |
2022-02-16 6:59 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
12,551 | $4.1942 | $52,642 | 5,188,337 (Direct) |
View |
2022-02-14 Purchase |
2022-02-16 6:54 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
12,551 | $4.1942 | $52,642 | 10,374,123 (Indirect Direct) |
View |
2022-02-10 Purchase |
2022-02-14 7:19 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
17,500 | $4.4514 | $77,900 | 5,175,786 (Indirect) |
View |
2022-02-10 Purchase |
2022-02-14 7:18 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
17,500 | $4.4514 | $77,900 | 5,175,786 (Direct) |
View |
2022-02-03 Purchase |
2022-02-08 6:42 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
30,000 | $4.5267 | $135,800 | 5,158,286 (Direct) |
View |
2022-02-03 Purchase |
2022-02-08 6:40 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
30,000 | $4.5267 | $135,800 | 5,158,286 (Indirect) |
View |
2022-01-27 Purchase |
2022-01-31 11:30 am |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
15,000 | $4.2566 | $63,849 | 5,128,286 (Direct) |
View |
2022-01-27 Purchase |
2022-01-31 11:26 am |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
15,000 | $4.2566 | $63,849 | 5,128,286 (Indirect) |
View |
2022-01-25 Purchase |
2022-01-27 10:31 am |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
50,000 | $4.7165 | $235,824 | 5,113,286 (Indirect) |
View |
2022-01-25 Purchase |
2022-01-27 10:26 am |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
50,000 | $4.7165 | $235,824 | 5,113,286 (Direct) |
View |
2022-01-21 Purchase |
2022-01-25 09:14 am |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
47,410 | $4.8203 | $228,529 | 5,063,286 (Indirect) |
View |
2022-01-21 Purchase |
2022-01-25 09:12 am |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
47,410 | $4.8203 | $228,529 | 5,063,286 (Direct) |
View |
2022-01-19 Purchase |
2022-01-21 6:20 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
30,244 | $5.1023 | $154,313 | 5,015,876 (Indirect) |
View |
2022-01-19 Purchase |
2022-01-21 6:16 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
30,244 | $5.1023 | $154,313 | 5,015,876 (Direct) |
View |
2022-01-18 Purchase |
2022-01-20 09:07 am |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
10,000 | $5.08 | $50,800 | 4,985,632 (Indirect) |
View |
2022-01-18 Purchase |
2022-01-20 09:05 am |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
10,000 | $5.08 | $50,800 | 4,985,632 (Direct) |
View |
2022-01-13 Purchase |
2022-01-18 10:20 am |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
26,172 | $5.0967 | $133,392 | 4,975,632 (Indirect) |
View |
2022-01-13 Purchase |
2022-01-18 10:17 am |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
26,172 | $5.0967 | $133,392 | 4,975,632 (Direct) |
View |
2022-01-11 Purchase |
2022-01-13 4:14 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
20,047 | $5.1984 | $104,212 | 4,949,460 (Indirect) |
View |
2022-01-11 Purchase |
2022-01-13 4:13 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
20,047 | $5.1984 | $104,212 | 4,949,460 (Direct) |
View |
2022-01-10 Purchase |
2022-01-11 3:29 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
10,000 | $5.28 | $52,800 | 4,929,413 (Indirect) |
View |
2022-01-10 Purchase |
2022-01-11 3:22 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
10,000 | $5.28 | $52,800 | 4,929,413 (Direct) |
View |
2021-12-30 Purchase |
2022-01-03 09:40 am |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
1,127 | $4.85 | $5,466 | 4,919,413 (Indirect) |
View |
2021-12-30 Purchase |
2022-01-03 09:38 am |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
1,127 | $4.85 | $5,466 | 4,919,413 (Direct) |
View |
2021-12-29 Purchase |
2021-12-30 12:25 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
69,000 | $4.98 | $343,620 | 4,918,286 (Indirect) |
View |
2021-12-29 Purchase |
2021-12-30 12:24 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
69,000 | $4.98 | $343,620 | 4,918,286 (Direct) |
View |
2021-12-28 Purchase |
2021-12-29 12:04 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
11,288 | $5.28 | $59,601 | 4,849,286 (Indirect) |
View |
2021-12-28 Purchase |
2021-12-29 11:37 am |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
11,288 | $5.28 | $59,601 | 4,849,286 (Direct) |
View |
2021-12-27 Purchase |
2021-12-27 6:08 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
3,712 | $5.3 | $19,674 | 4,837,998 (Indirect) |
View |
2021-12-27 Purchase |
2021-12-27 6:04 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
3,712 | $5.3 | $19,674 | 4,837,998 (Direct) |
View |
2021-12-23 Purchase |
2021-12-23 6:55 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
11,000 | $5.27 | $57,970 | 4,834,286 (Indirect) |
View |
2021-12-23 Purchase |
2021-12-23 6:53 pm |
Sensei Biotherapeutics Inc. | SNSE | Cambrian BioPharma Inc 10% Owner |
11,000 | $5.27 | $57,970 | 4,834,286 (Direct) |
View |
2021-12-17 Purchase |
2021-12-21 3:54 pm |
Sensei Biotherapeutics Inc. | SNSE | Peyer James Director 10% Owner |
117 | $5.29 | $619 | 4,823,286 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-02-15 Option Award |
2022-02-17 6:23 pm |
N/A 2032-02-14 |
Sensei Biotherapeutics Inc. | SNSE | Pierce Robert Hamilton Chief R&D Officer |
83,000 | $0 | 83,000 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 6:21 pm |
N/A 2032-02-14 |
Sensei Biotherapeutics Inc. | SNSE | Colgan Erin Chief Financial Officer |
83,000 | $0 | 83,686 (Direct) |
View |
2022-02-15 Option Award |
2022-02-17 6:20 pm |
N/A 2032-02-14 |
Sensei Biotherapeutics Inc. | SNSE | Celebi John President and CEO |
215,500 | $0 | 215,714 (Direct) |
View |